Enalapril (marketed as Vasotec in the USA Enaladex in some other countries and Enacard for veterinary use) is an angiotensin converting enzyme (ACE) inhibitor used in the treatment of hypertension diabetic nephropathy and some types of chronic heart failure. ACE converts the peptide hormone angiotensin I to angiotensin II. One of the actions of angiotensin II is the vasoconstriction of blood vessels resulting in an increase in blood pressure.
thumbnail
ATC prefix
C09
ATC suffix
AA02
Bioavailability
60.0
CAS number
75847-73-3
ChEBI
4784
DrugBank
DB00584
FDA UNII code
69PN84IO1A
IUPAC name
(2S)-1-[(2S)-2-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]aminopropanoyl]pyrrolidine-2-carboxylic acid (Diagrams above are enalapril and enalaprilat respectively. Data below refers to enalapril unless indicated)
This page contains content from the copyrighted Wikipedia article "Enalapril"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
